ACC.22: Medtronic renal denervation system demonstrates significant blood pressure reduction through three years

/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced long-term data from the first 80 patients in the SPYRAL...

Related Keywords

Ireland ,Germany ,Japan ,United States ,Saarland ,Washington ,Dublin ,Canada ,Jason Weidman ,Medtronic Symplicity Spyral ,Symplicity Spyral ,Felix Mahfoud ,Coll Cardiol ,Prnewswire Medtronic ,Ryan Weispfenning ,Jeffrey Popma ,Krystin Hayward Leong ,Linkedin ,American College Of Cardiology ,Exchange Commission ,Medtronic ,Global Clinical Program ,Our Mission ,Saarland University Hospital In Homburg ,American College ,Annual Scientific Session ,Renal Denervation ,Saarland University Hospital ,Structural Heart ,Cardiovascular Portfolio ,Clinical Program ,Global Symplicity Registry ,Medtronic Plc ,